David A Frank

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Venues

Cancers

Clinical cancer research : an official journal of the American Association for Cancer Research

Metabolites

Cancer research

Yale University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Yale University

United States

PHD :: Pharmacology

Massachusetts Institute of Technology

United States

BSC :: Biology

Publications

Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad, Tiara Hamilton, David A Frank
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation. Cancers 16 (7) (2024)
Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad, Tiara Hamilton, David A Frank
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation. Cancers 16 (7) (2024)
Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad, Tiara Hamilton, David A Frank
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation. Cancers 16 (7) (2024)
Michael J Hochman, David A Frank
Dissecting Out a Rare Mutation, STAT: Features of STAT3-Mutant Myeloid Neoplasms. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad, Tiara Hamilton, David A Frank
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation. Cancers 16 (7) (2024)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Jennifer I Brown, Peng Wang, Alan Y L Wong, Boryana Petrova, Rosanne Persaud, Sepideh Soukhtehzari, Melanie Lopez McDonald, Danielle Hanke, Josephine Christensen, Petar Iliev, Weiyuan Wang, Daniel K Everton, Karla C Williams, David A Frank, Naama Kanarek, Brent D G Page
Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity. Metabolites 13 (2) (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Jennifer I Brown, Peng Wang, Alan Y L Wong, Boryana Petrova, Rosanne Persaud, Sepideh Soukhtehzari, Melanie Lopez McDonald, Danielle Hanke, Josephine Christensen, Petar Iliev, Weiyuan Wang, Daniel K Everton, Karla C Williams, David A Frank, Naama Kanarek, Brent D G Page
Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity. Metabolites 13 (2) (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Jennifer I Brown, Peng Wang, Alan Y L Wong, Boryana Petrova, Rosanne Persaud, Sepideh Soukhtehzari, Melanie Lopez McDonald, Danielle Hanke, Josephine Christensen, Petar Iliev, Weiyuan Wang, Daniel K Everton, Karla C Williams, David A Frank, Naama Kanarek, Brent D G Page
Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity. Metabolites 13 (2) (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Laura E Stevens, Guillermo Peluffo, Xintao Qiu, Daniel Temko, Anne Fassl, Zheqi Li, Anne Trinh, Marco Seehawer, Bojana Jovanovic, Maša Alečković, Callahan M Wilde, Renee C Geck, Shaokun Shu, Natalie L Kingston, Nicholas W Harper, Vanessa Almendro, Alanna L Pyke, Shawn B Egri, Malvina Papanastasiou, M Kendell Clement, Ningxuan Zhou, Sarah R Walker, Jacqueline Salas, So Yeon Park, David A Frank, Alexander Meissner, Jacob D Jaffe, Piotr Sicinski, Alex Toker, Franziska Michor, Henry W Long, Beth A Overmoyer, Kornelia Polyak
JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states. Cancer research (2022)
David A Frank
Cyclin-Dependent Kinase 4/6 Inhibitors: Is a Noncanonical Substrate the Key Target? Cancer research 82 (7) (2022)
Bo-Rui Chen, Anagha Deshpande, Karina Barbosa, Maria Kleppe, Xue Lei, Narayana Yeddula, Pablo Sánchez Vela, Alexandre Rosa Campos, Robert J Wechsler-Reya, Anindya Bagchi, Soheil Meshinchi, Connie Eaves, Irmela Jeremias, Torsten Haferlach, David A Frank, Ze'ev A Ronai, Sumit Chanda, Scott A Armstrong, Peter D Adams, Ross L Levine, Aniruddha J Deshpande
A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis in AF10-rearranged AML. Blood 137 (24) (2021)
Li Wang, Matteo Astone, Sk Kayum Alam, Zhu Zhu, Wuhong Pei, David A Frank, Jason W Sinclair, Luke H Hoeppner
Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability. Disease models & mechanisms 14 (11) (2021)
Jennifer R Brown, Sarah R Walker, Lisa N Heppler, Svitlana Tyekucheva, Erik A Nelson, Josephine Klitgaard, Maria Nicolais, Yasmin Kroll, Michael Xiang, Jennifer E Yeh, Mousumi Chaudhury, Zachary T Giaccone, Stacey M Fernandes, Eric D Jacobsen, David C Fisher, Arnold S Freedman, Matthew S Davids, Jeffrey G Supko, Catherine Wu, David A Frank
Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses. American journal of hematology 96 (4) (2021)
Suhu Liu, Helen I Gandler, Isidora Tošić, Darwin Q Ye, Zachary T Giaccone, David A Frank
Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer. Molecular cancer research : MCR 19 (8) (2021)
Moshe Lapidot, Abigail E Case, Dalia Larios, Helen I Gandler, Chengcheng Meng, Isidora Tošić, Ellen L Weisberg, Michael J Poitras, Prafulla C Gokhale, Cloud P Paweletz, Klaus Podar, Ravi Salgia, Srinivas V Saladi, James D Griffin, David A Frank, Raphael Bueno, Martin Sattler
Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM). Cancers 13 (1) (2020)

David A Frank.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David A Frank